Binding study of semotiadil and levosemotiadil with human serum albumin using high-performance frontal analysis

Analytical Sciences

Volumn 15, Issue 3, 1999, Pages 217-222

  Rosas, Maria Esther Rodriguez ^a   Shibukawa, Akimasa ^a   Yoshikawa, Yuki ^a   Kuroda, Yoshihiro ^a   Nakagawa, Terumichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Albumin; High performance frontal analysis; High performance liquid chromatography; Levosemotiadil; Protein binding; Semotiadil

Indexed keywords

BIOCHEMISTRY; ENANTIOMERS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ALBUMIN; FRONTAL ANALYSIS; LEVOSEMOTIADIL; PROTEIN BINDING; SEMOTIADIL;

BINDING ENERGY;

ANTIARRHYTHMIC AGENT; HUMAN SERUM ALBUMIN; LEVOSEMOTIADIL; SESAMODIL FUMARATE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; DRUG BINDING; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PROTEIN BINDING;

EID: 0033372227     PISSN: 09106340     EISSN: None     Source Type: Journal    
DOI: 10.2116/analsci.15.217     Document Type: Article

References (40)

1. M. C. Meyer and D. E. Guttman, J. Pharm. Sci., 57, 895 (1968).
2. J. J. Vallner, J. Pharm. Sci., 66, 447 (1977).
3. T. C. Kwong, Clin. Chem. Acta, 151, 193 (1985).
4. U. Kragh-Hansen, Pharmacol. Rev., 33, 17 (1981).
5. K. J. Fehske, W. E. Mueller and U. Wollert, Biochem. Pharmacol., 30, 687 (1981).
6. G. T. Tucker and M. S. Lennard, Phamac. Ther., 45, 309 (1989).
7. T. Noctor, "Drug Stereochemistry", ed, I. W. Wainer, 2nd ed., Chap. 12, Dekker, New York, 1993.
8. A. Shibukawa, T. Nakagawa, N. Nishimura, M. Miyake and H. Tanaka, Chem. Pharm. Bull., 37, 702 (1989).
9. A. Shibukawa, N. Nishimura, K. Nomura, Y. Kuroda and T. Nakagawa, Chem. Pharm. Bull., 38, 443 (1990).
10. A. Shibukawa, M. Nagao, Y. Kuroda and T. Nakagawa, Anal. Chem., 62, 712 (1990).
11. N. Nishimura, A. Shibukawa and T. Nakagawa, Anal. Sci., 6, 355 (1990).
12. A. Shibukawa, A. Terakita, J. He and T. Nakagawa, J. Pharm. Sci., 81, 710 (1992).
13. A. Terakita, A. Shibukawa and T. Nakagawa, Anal. Sci., 9, 229 (1993).
14. A. Shibukawa, M. Nagao, A. Terakita, J. He and T. Nakagawa, J. Liq. Chromatogr., 16, 903 (1993).
15. A. Shibukawa, C. Nakao, T. Sawada, T. Terakita, N. Morokoshi and T. Nakagawa, J. Pharm. Sci., 83, 868 (1994).
16. A. Terakita, A. Shibukawa and T. Nakagawa, Anal. Sci., 10, 11 (1994).
17. A. Shibukawa, M. Kadohara, J. He, M. Nishimura, S. Naito and T. Nakagawa, J. Chromatogr. A, 694, 81 (1995).
18. A. Shibukawa, T. Sawada, C. Nakao, T. Izumi and T. Nakagawa, J. Chromatogr. A, 697, 337 (1995).
19. A. Shibukawa and T. Nakagawa, Anal. Chem., 68, 447 (1996).
20. J. He, A. Shibukawa, S. Tokunaga and T. Nakagawa, J. Pharm. Sci., 86, 120 (1997).
21. M. E. Rodriguez Rosas, A. Shibukawa, K. Ueda and T. Nakagawa, J. Pharm. Biomed. Anal., 15, 1595 (1997).
22. A. Shibukawa, Y. Yoshimoto, T. Ohara and T. Nakagawa, J. Pharm. Sci., 83, 616 (1994).
23. T. Ohara, A. Shibukawa, T. Nakagawa, Anal. Chem., 67, 3520 (1995).
24. H. Shiono, A. Shibukawa, Y. Kuroda and T. Nakagawa, Chirality, 9, 291 (1997).
25. G. Stark, K. Kasper, U. Stark, N. Miyawaki, M. Decrinis and H. A. Tritthart, Eur. J. Pharmacol., 286, 71 (1995).
26. M. Kageyama, T. Yanagisawa and N. Taira, Br. J. Pharmacol., 114, 1289 (1995).
27. N. Miyawaki, T. Furuta, T. Shigei, H. Yamauchi and T. Iso, J. Cardiovasc. Pharmacol., 16, 769 (1990).
28. N. Teramoto, Jpn. J. Pharmacol., 61, 183 (1993).
29. K. Nishimura, N. Miyawaki, H. Yamauchi and T. Iso, Arzneimittelforschung., 40, 244 (1990).
30. M. Kageyama, K. Nishimura, T. Takada, N. Miyawaki and H. Yamauchi, J. Cardiovasc. Pharmacol., 17, 102 (1991).
31. T. Takada, N. Miyawaki, M. Kageyama, K. Matsuno, N. Ishida, H. Yamauchi and T. Iso, J. Cardiovas. Pharmacol., 18, 855 (1991).
32. T. Mori, K. Irie and S. Ashida, Jpn. J. Pharmacol., 55 (suppl. 1), 328 (1991).
33. T. Mori, K. Irie, F. Ishii and S. Ashida, Jpn. J. Pharmacol., 52 (suppl. 1), 203 (1990).
34. I. Kodama, R. Suzuki, K. Maruyama and J. Toyama, Br. J. Pharmacol., 114, 503 (1995).
35. K. Nakayama, K. Morimoto, Y. Nazawa and Y. Tanaka, J. Cardiovasc. Pharmacol., 20, 380 (1992).
36. N. Miyawaki, F. Yamazaki, T. Furuta, T. Shigei, H. Yamauchi, Drug Dev. Res., 22, 293 (1991).
37. S. Nagashima, T. Uematsu, T. Araki, M. Matsuzaki, H. Fukuchi and M. Nakashima, Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 688 (1992).
38. A. Hirasawa, A. Haruno, T. Matsuzaki and K. Hashimoto, Jpn. Heart J., 33, 851 (1992).
39. M. Fukuchi, T. Uematsu, S. Nagashima and M. Nakashima, Naunyn-Schmiedeberg's Arch. Pharmacol., 341, 557 (1990).
40. Y. Hara and H. Nakaya, Br. J. Pharmacol., 116, 2750 (1995).